Map of our members

 

Member Directory

Approved
Shemanko
Approved
Nicola Aceto
Institution: University of Basel
Approved
Caroline Alexander
Institution: University of Wisconsin-Madison
Approved
Cinzia Allegrucci
Institution: SVMS and Centre for Genetics and Genomics, University of Nottingham
Approved
Eran Andrechek
Institution: Michigan State University
Approved
Joaquin Arribas
Institution: Vall d'Hebron Institute of Oncology (VHIO) and CIBERONC
Approved
Itamar Barash
Institution: ARO, The Volcani Center
Approved
Mohamed Bentires-Alj
Institution: Department of Biomedicine University of Basel / University Hospital Basel
Approved
Daniel BIRNBAUM
Institution: Centre de Recherche en Cancérologie de Marseille, UMR599 Inserm and Institut Paoli-Calmettes
Approved
Leander Blaas
Institution: Karolinska Institutet
Approved
Giuseppina (Giusy) Bonizzi
Institution: European oncology institute (IEO)
Approved
Anne-Lise Børresen-Dale
Institution: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
Approved
MARC BRACKE
Institution: Laboratory of Experimental Cancer Research, Department of Radiotherapy and Nuclear Medicine, University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium.
Approved
William Brackenbury
Institution: University of York
Approved
Vania Braga
Institution: Molecular Medicine, NHLI, Faculty of MedicineImperial College London
Approved
Cathrin Brisken
Institution: Swiss Institute for Experimental Cancer Research (ISREC)School of Life SciencesEcole Polytechnique Fédérale de Lausanne (EPFL)
Approved
Xose Bustelo
Institution: Salamanca Cancer Research Center / Centro de Investigacion del Cancer de Salamanca
Approved
Carlos Caldas
Institution: Cancer Research UK Cambridge Research Institute and Department of Oncology, University of Cambridge
Approved
Toni Celià-Terrassa
Institution: Hospital del Mar Medical Research Institute (IMIM); PRBB
Approved
Biancastella Cereser
Institution: Imperial College London
Approved
Alain Chariot
Institution: Interdisciplinary Cluster for Applied Genoproteomics, Medical Chemistry Unit, University of Liege, Belgium
Approved
Xi Chen
Institution: Baylor College of Medicine
Approved
Saverio Cinti
Institution: Dept. of Experimental and Clinical Medicine, School of Medicine, University of Ancona (Politecnica delle Marche), Ancona, Italy
Approved
Rob Clarke
Institution: University of Manchester
Approved
Richard Clarkson
Institution: University of Cardiff School of Biosciences
Approved
R Charles Coombes
Institution: Imperial College
Approved
Pam Cowin
Institution: NYUSOM
Approved
Maria Grazia Daidone
Institution: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (MI)
Approved
Trevor Dale
Institution: Cardiff University
Approved
Felicity Davis
Institution: Mater Research Institute-University of Queensland
Approved
Patrick Derksen
Institution: University Medical Center Utrecht / Pathology
Approved
Christine Desmedt
Institution: KU Leuven
Approved
Eve Devinoy
Institution: Institut National de la Recherche Agronomique (INRA)
Approved
Pier Paolo Di Fiore
Institution: Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milan (Italy) and FIRC Institute of Molecular Oncology (IFOM) Foundation, Via Adamello 16, Milano, Italy
Approved
Gabriela Dontu
Institution: King's College iLondon
Approved
Camila dos Santos
Institution: Cold Spring Harbor Laboratory
Approved
Paul Edwards
Institution: Department of Pathology and Cancer research UK Cambridge Institute, University of Cambridge
Approved
Salah Elias
Institution: University of Southampton
Approved
Gillian Farnie
Institution: University of Oxford
Approved
INGVAR FERBY
Institution: Ludwig Institute for Cancer Research Ltd
Approved
David Flint
Institution: Strathclyde University
Approved
Silvia Fre
Institution: Institut Curie
Approved
William Gallagher
Institution: UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
Approved
Pere Gascón
Institution: IDIBAPS-Hospital Clinic, Barcelona
Approved
Julia Gee
Institution: Breast Cancer (Molecular Pharmacology) Group, School of Pharmacy & Pharmacuetical Sciences, Cardiff University, Cardiff CF10 3NB, United Kingdom
Approved
Vasiliki Gkretsi
Institution: University of Cyprus
Approved
Marina Glukhova
Institution: UMR 144 CNRS-Institut Curie, Institut Curie, Centre de Recherche
Approved
Roger Gomis
Institution: Institute for Research in Biomedicine (IRB Barcelona)
Approved
anne gompel
Institution: INSERM UMRS 938 Saint Antoine, ParisParis Descartes University
Approved
Eva Gonzalez Suarez
Institution: Bellvitge Institute for Biomedica Research (IDIBELL) Cancer Epigenetics and Biology Program (PEBC)
Approved
Bernd Groner
Institution: Georg Speyer Haus, Institute for Biomedical Research, Paul Ehrlich Str. 42, D-60596 Frankfurt am Main, Germany
Approved
Wenjun Guo
Institution: Albert Einstein College of Medicine
Approved
Sanjeev Gupta
Institution: Lambe Institute for Translational ResearchNational University of Ireland Galway
Approved
Bala Gur Dedeoglu
Institution: Ankara University Biotechnology Institute
Approved
Kristina Havas
Institution: IFOM- Italian Foundation of Molecular Oncology
Approved
Luisa Helguero
Institution: Department of Medical Sciences, University of Aveiro
Approved
John Hilkens
Institution: Netherlands Cancer Institute
Approved
Ann Hopkins
Institution: Royal College of Surgeons in Ireland
Approved
Russ Hovey
Institution: University of California, Davis
Approved
Beatrice Howard
Institution: Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London
Approved
Thomas A Hughes
Institution: University of Leeds
Approved
Nancy Hynes
Institution: Friedrich Miescher Institute for Biomedical Research
Approved
Richard Iggo
Institution: Bergonie Cancer Institute, University of Bordeaux
Approved
Martin Jechlinger
Institution: European Molecular Biology Laboratory (EMBL)
Approved
D Joseph Jerry
Institution: University of Massachusetts-Amherst
Approved
Jos Jonkers
Institution: Netherlands Cancer Institute
Approved
Ute Jungwirth
Institution: University of Bath
Approved
Philip Kaenel
Institution: Department for Clinical Research University of Bern
Approved
Pekka Katajisto
Institution: University of Helsinki
Approved
Ruth Keri
Institution: Case Western Reserve University
Approved
Walid Khaled
Institution: University of CambridgeDepartment of Pharmacology
Approved
Juha Klefström
Institution: Medical Faculty, University of Helsinki
Approved
Zdenek Kleibl
Institution: Institute of biochemistry and experimental oncology, First faculty of medicine, Charles university in Prague
Approved
Zuzana Koledova
Institution: Masaryk University, Faculty of Medicine
Approved
Fabienne Le Provost
Institution: Laboratoire de Génétique Animale et Biologie Intégrative, Institut National de Recherche Agronomique (INRA)
Approved
Francoise LENFANT
Institution: INSERM U1048CHU Rangueil1 Avenue J. POUlhèsBP 8422531 432 Toulouse cedex 04
Approved
Carman Li
Institution: Harvard Medical School
Approved
David Llobet Navas
Institution: Bellvitge Biomedical Research Institute (IDIBELL)
Approved
Paul Lu
Institution: Paterson Institute for Cancer Research, Wellcome Trust Center for Cell Matrix Research, University of Manchester
Approved
Katrin Manda
Institution: Department of Radiotherapy and Radiation Oncology, University Medical Centre Rostock
Approved
Enni Markkanen
Institution: University of Zurich
Approved
Stewart Martin
Institution: University of Nottingham, School of Medicine, Division of Cancer and Stem Cells, Department of Clinical Oncology, Nottingham City Hospital, Nottingham NG5 1PB
Approved
Jochen Maurer
Institution: University Hospital Aachen (RWTH)
Approved
Arthur Mercurio
Institution: University of Massachusetts Medical School
Approved
Jens Henrik Norum
Institution: The Norwegian Radium Hospital Oslo University Hospital
Approved
Samantha Oakes
Institution: Garvan Institute of Medical Research
Approved
Gertraud OREND
Institution: INSERM U682, De l`homéostasie tissulaire au cancer et à l`inflammationEquipe: Impact du microenvironnement sur l`angiogenèse et l`invasion tumorale
Approved
Véronique Orian-Rousseau
Institution: Karlsruhe Institute of Technology, Institute for Toxicology and Genetics
Approved
Gilles PAGES
Institution: University of Nice Sophia Antipolis UMR CNRS 6543
Approved
Joana PAREDES
Institution: i3S - Institute of Investigation and Innovation in Health - University of Porto- EPIC (EPithelial Interactions in Cancer) lab
Approved
Diwakar Pattabiraman
Institution: Dartmouth College, Norris Cotton Cancer Center
Approved
Pier Giuseppe Pelicci
Institution: Experimental Oncology European Institute of Oncology and the Campus IFOM-IEO
Approved
Emilia Peuhu
Institution: University of Turku
Approved
Didier Picard
Institution: Department of Cell BiologyUniversity of Geneva
Approved
Alexandra Pietersen
Institution: National Cancer Centre Singapore & Duke-NUS Graduate Medical School
Approved
Lourdes Planelles
Institution: National Center for Biotechnology, CNB/CSIC
Approved
Lisa Privette Vinnedge
Institution: Cincinnati Children's Hospital Medical Center
Approved
Miquel Angel Pujana
Institution: Procure, Catalan Institute of Oncology, IDIBELL
Approved
Sabine Riethdorf
Institution: Institute of Tumor Biology, University Medical center Hamburg-Eppendorf, Germany
Approved
Marie-Christine Rio
Institution: Institut de Génétique et de Biologie Moléculaire et Cellulaire
Approved
Ruth Rodriguez Barrueco
Institution: Universitat de Barcelona - Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
Approved
Sven Rottenberg
Institution: Institute of Animal Pathology, Vetsuisse Faculty, University of Bern
Approved
Hege G. Russnes
Institution: Dept. of cancer genetics, Institute for cancer research and dept. of pathology, Oslo University Hospital
Approved
Erik Sahai
Institution: Cancer Research UK
Approved
Christina Scheel
Institution: Helmholtz Center Munich
Approved
Fernando Schmitt
Institution: IPATIMUP, Institute of Molecular Pathology and Immunology of Porto University, Rua Dr. Roberto Frias, s/n4200-465 PortoPortugalRua Dr. Roberto Frias, s/n
Approved
Cora-Ann Schoenenberger
Institution: Institute for Chemistry, University of Basel
Approved
Wolfgang Schreibmayer
Institution: Medical University of Graz; Research Unit on "Ion Channels in Cancer Biology"
Approved
Linda Schuler
Institution: University of Wisconsin--Madison
Approved
VIOLETA SERRA
Institution: Vall d'Hebron Institute of Oncology - Barcelona
Approved
Priyanka Sharma
Institution: Center for Genomic Regulation
Approved
Angels Sierra
Institution: IDIBELL
Approved
Marina Simian
Institution: Instituto de Oncología "Angel H. Roffo"
Approved
Jonathan Sleeman
Institution: University of Heidelberg, Medical Faculty Mannheim, Ludolf-Krehl-Str 13-17, 68167 Mannheim, Germany and Forschungszentrum Karlsruhe, Institut für Toxikologie und Genetik, Postfach 3640, 76021 Karlsruhe, Germany
Approved
Matt Smalley
Institution: European Cancer Stem Cell Research Institute, Cardiff School of Biosciences, Cardiff
Approved
Gilbert Smith
Institution: National Cancer Institute
Approved
Arnoud Sonnenberg
Institution: The Netherlands Cancer Inst.
Approved
Therese Sørlie
Institution: Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital
Approved
Justin Stebbing
Institution: Imperial College London
Approved
Torsten Stein
Institution: FU Berlin
Approved
Esta Sterneck
Institution: National Cancer Institute
Approved
Charles Streuli
Institution: University of Manchester
Approved
Triantafyllos Stylianopoulos
Institution: University of Cyprus
Approved
Alex Swarbrick
Institution: Garvan Institute of Medical Research
Approved
Mario P. Tschan
Institution: Experimental Pathology, TP2, University of Bern
Approved
ALECIA-JANE TWIGGER
Institution: Hartmann Human Lactation Research Group,The University of Western Australia
Approved
Ahmet Ucar
Institution: University of Manchester
Approved
Arzu Umar
Institution: Erasmus University Medical Center Rotterdam
Approved
Renee van Amerongen
Institution: University of Amsterdam
Approved
Bob van de Water
Institution: Division of Toxicology, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands
Approved
Maarten van Lohuizen
Institution: The Netherlands Cancer Institute
Approved
Jacco van Rheenen
Institution: Hubrecht Institute
Approved
Bart Vanhaesebroeck
Institution: Centre for Cell Signalling - Institute of Cancer - Barts and the London Medical School -
Approved
Bianca Maria Veneziani
Institution: Dipartimento di Medicina Molecolare e Biotecnologie Mediche Scuola di Medicina e Chirurgia Università di Napoli "Federico II"
Approved
Maria VIVANCO
Institution: CIC bioGUNE, Cell Biology and Stem Cells Unit, Bilbao, SPAIN
Approved
Bjoern von Eyss
Institution: Leibniz Institute on Aging - Fritz Lipmann Institute
Approved
Lalage Wakefield
Institution: National Cancer Institute
Approved
Christine Watson
Institution: University of cambridge
Approved
Jukka Westermarck
Institution: Centre for Biotechnology, University of Turku
Approved
Bruce Whitelaw
Institution: Roslin Institute and Royal (Dick) School of Veterinary StudiesUniveristy fo EdinburghRoslinMidlothian EH25 9PS, UK
Approved
Lisa Wiesmüller
Institution: Gynaecological Oncology, HeadDepartment of Obstetrics and Gynaecology of the University of Ulm
Approved
Terri Wood
Institution: New Jersey Medical School Cancer Center/Rutgers Biomedical & Health Sciences
Approved
Leonie Young
Institution: Royal College of Surgeons in Ireland
Approved
ROSA ZARAGOZÁ
Institution: University of Valencia
Approved
Xiang Zhang
Institution: Baylor College of Medicine
Approved
alessio zippo
Institution: CIBIO, University of Trento